Boosting bone regeneration using augmented melt-extruded additive-manufactured scaffolds
Source abstract
Abstract
Bone tissue engineering (BTE) is in active search of the ideal scaffold to give a clinical solution for bone regeneration in non-union fractures. During the last decades, the use of additive manufacturing (AM), and, in particular, melt extrusion AM (ME-AM), has been investigated towards this aim. ME-AM enables the fabrication of personalized 3D scaffolds, with a controlled and highly interconnected porosity, through the solvent-free processing of biodegradable and mechanically robust polymers. In addition to these properties matching the requirements for BTE scaffolds, the polymers used to fabricate these constructs are also more amenable for further functionalization than metals or ceramics, to influence cell behaviour, making thermoplastic materials a preferred choice for BTE. This review provides a comprehensive analysis of various ME-AM scaffolds developed for BTE, along with approaches used to augment their bioactivity, which includes architectural, surface physical and chemical modifications, the incorporation of secondary fibrous or hydrogel networks within the scaffold pores, and the use of composites for ME-AM scaffold fabrication.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Additive Manufacturing and 3D Printing Technologies · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Complex Tissue Regeneration Department, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands
Funding
H2020 Industrial Leadership
References (100+)
Show source-provided references
1. 10.1002/btpr.24610.1002/btpr.246 ↗
2. 10.1016/S1350-4533(98)00007-110.1016/S1350-4533(98)00007-1 ↗
3. 10.2106/00004623-199508000-0001910.2106/00004623-199508000-00019 ↗
4. Keaveny TM · 2003 · 1
5. 10.1016/0021-9290(75)90075-510.1016/0021-9290(75)90075-5 ↗
6. 10.1016/S0021-9290(98)00057-810.1016/S0021-9290(98)00057-8 ↗
7. 10.1016/S0021-9290(01)00011-210.1016/S0021-9290(01)00011-2 ↗
8. 10.1016/0021-9290(93)90042-D10.1016/0021-9290(93)90042-D ↗
9. 10.1002/ar.109149030310.1002/ar.1091490303 ↗
10. 10.1016/S8756-3282(01)00619-610.1016/S8756-3282(01)00619-6 ↗
11. 10.1242/jcs.06303210.1242/jcs.063032 ↗
12. 10.1302/0301-620X.87B2.1587410.1302/0301-620X.87B2.15874 ↗
13. 10.1016/j.injury.2011.03.03110.1016/j.injury.2011.03.031 ↗
14. Research and markets. U.S. Market for Orthopedic Biomaterials 2010; 2010.
15. Green E · J Surg Orthop Adv · 2005 · 14 · 64
16. 10.1016/j.injury.2011.04.00410.1016/j.injury.2011.04.004 ↗
17. 10.1016/j.injury.2011.03.03610.1016/j.injury.2011.03.036 ↗
18. 10.1016/j.otsr.2011.11.00110.1016/j.otsr.2011.11.001 ↗
19. 10.2106/JBJS.J.0151310.2106/JBJS.J.01513 ↗
20. 10.1308/003588410X1251883643932610.1308/003588410X12518836439326 ↗
21. 10.1016/j.addr.2012.06.00810.1016/j.addr.2012.06.008 ↗
22. 10.1007/978-3-030-15089-1_2810.1007/978-3-030-15089-1_28 ↗
23. 10.4248/BR20130300210.4248/BR201303002 ↗
24. 10.1016/S0142-9612(00)00121-610.1016/S0142-9612(00)00121-6 ↗
25. 10.1016/j.jmbbm.2007.11.00210.1016/j.jmbbm.2007.11.002 ↗
26. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
27. 10.1016/j.actbio.2012.04.00110.1016/j.actbio.2012.04.001 ↗
28. 10.1039/C4BM00291A10.1039/C4BM00291A ↗
29. 10.1098/rsif.2008.006410.1098/rsif.2008.0064 ↗
30. 10.1002/adhm.20120015910.1002/adhm.201200159 ↗
31. 10.22203/eCM.v005a0310.22203/eCM.v005a03 ↗
32. 10.1016/j.actbio.2018.09.03110.1016/j.actbio.2018.09.031 ↗
33. 10.1002/term.163510.1002/term.1635 ↗
34. 10.1016/j.tibtech.2017.10.01510.1016/j.tibtech.2017.10.015 ↗
35. 10.1007/978-1-0716-0611-7_710.1007/978-1-0716-0611-7_7 ↗
36. 10.1016/j.actbio.2010.09.03910.1016/j.actbio.2010.09.039 ↗
37. 10.1016/j.msec.2016.04.01410.1016/j.msec.2016.04.014 ↗
38. 10.1002/pi.533210.1002/pi.5332 ↗
39. 10.1016/j.biomaterials.2010.04.05010.1016/j.biomaterials.2010.04.050 ↗
40. 10.1016/j.tibtech.2004.05.00510.1016/j.tibtech.2004.05.005 ↗
41. 10.1016/0002-9610(74)90228-110.1016/0002-9610(74)90228-1 ↗
42. 10.1016/0142-9612(95)93577-Z10.1016/0142-9612(95)93577-Z ↗
43. 10.1016/j.arthro.2006.04.09610.1016/j.arthro.2006.04.096 ↗
44. 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-710.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-7 ↗
45. Schantz J-T · Oper Neurosurg · 2006 · 58
46. Low SW · Singapore Med J · 2009 · 50 · 777
47. 10.1088/1758-5090/aa576610.1088/1758-5090/aa5766 ↗
48. 10.2217/3dp-2019-002210.2217/3dp-2019-0022 ↗
49. 10.1111/clr.1248610.1111/clr.12486 ↗
50. 10.3109/01676830.2015.101526310.3109/01676830.2015.1015263 ↗
51. 10.1016/S0168-3659(01)00497-710.1016/S0168-3659(01)00497-7 ↗
52. 10.4236/jbise.2009.2100710.4236/jbise.2009.21007 ↗
53. 10.1002/jbm.b.3158810.1002/jbm.b.31588 ↗
54. 10.1016/j.jobcr.2019.10.00310.1016/j.jobcr.2019.10.003 ↗
55. 10.1089/ten.teb.2019.022410.1089/ten.teb.2019.0224 ↗
56. 10.1111/cpr.1227210.1111/cpr.12272 ↗
57. 10.3390/colloids302004310.3390/colloids3020043 ↗
58. 10.1088/1758-5090/8/2/02502010.1088/1758-5090/8/2/025020 ↗
59. 10.1016/S0142-9612(01)00232-010.1016/S0142-9612(01)00232-0 ↗
60. 10.1016/j.biomaterials.2005.07.02310.1016/j.biomaterials.2005.07.023 ↗
61. 10.1016/j.actbio.2019.11.04110.1016/j.actbio.2019.11.041 ↗
62. Ostrowska B, Di Luca A, Moroni L, et al. Influence of internal pore architecture on biological and mechanical properties of three-dimensional fiber deposited scaffolds for bone regeneration. Biomed Mater Res A. 2016 Apr;104(4):991–1001.10.1002/jbm.a.35637 ↗
63. 10.1088/1748-605X/ab38c610.1088/1748-605X/ab38c6 ↗
64. 10.1002/bit.2520010.1002/bit.25200 ↗
65. 10.1088/1758-5090/ab0f5910.1088/1758-5090/ab0f59 ↗
66. 10.1016/j.actbio.2010.11.00310.1016/j.actbio.2010.11.003 ↗
67. 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G ↗
68. 10.1021/bp010087810.1021/bp0100878 ↗
69. 10.1038/srep2289810.1038/srep22898 ↗
70. 10.2174/13862070978868189910.2174/138620709788681899 ↗
71. 10.1002/adhm.20160008310.1002/adhm.201600083 ↗
72. 10.1016/j.ijom.2013.05.00810.1016/j.ijom.2013.05.008 ↗
73. 10.1088/1748-605X/aa9bbc10.1088/1748-605X/aa9bbc ↗
74. 10.1002/jbm.a.3238110.1002/jbm.a.32381 ↗
75. 10.1021/la062192310.1021/la0621923 ↗
76. 10.1038/nmat201310.1038/nmat2013 ↗
77. 10.1016/j.biomaterials.2014.07.01510.1016/j.biomaterials.2014.07.015 ↗
78. 10.1002/adma.20190434110.1002/adma.201904341 ↗
79. 10.1038/s41598-018-33245-w10.1038/s41598-018-33245-w ↗
80. 10.1016/j.biomaterials.2012.02.04810.1016/j.biomaterials.2012.02.048 ↗
81. 10.1016/j.biomaterials.2011.08.05410.1016/j.biomaterials.2011.08.054 ↗
82. 10.1088/1748-605X/aaeb8210.1088/1748-605X/aaeb82 ↗
83. 10.1021/acsbiomaterials.8b0101810.1021/acsbiomaterials.8b01018 ↗
84. 10.1016/j.msec.2018.02.00810.1016/j.msec.2018.02.008 ↗
85. 10.1038/s41467-020-20865-y10.1038/s41467-020-20865-y ↗
86. 10.1016/j.biomaterials.2007.07.04910.1016/j.biomaterials.2007.07.049 ↗
87. 10.1007/s10856-005-6988-110.1007/s10856-005-6988-1 ↗
88. 10.1089/ten.tea.2016.016110.1089/ten.tea.2016.0161 ↗
89. 10.1016/j.compositesb.2018.06.02910.1016/j.compositesb.2018.06.029 ↗
90. 10.1016/j.msec.2020.11069310.1016/j.msec.2020.110693 ↗
91. 10.1021/acsomega.8b0202410.1021/acsomega.8b02024 ↗
92. 10.1533/9780857098104.2.20210.1533/9780857098104.2.202 ↗
93. 10.1016/j.biomaterials.2004.01.06210.1016/j.biomaterials.2004.01.062 ↗
94. 10.1016/j.biomaterials.2006.05.00110.1016/j.biomaterials.2006.05.001 ↗
95. 10.1016/S0021-9258(19)50210-110.1016/S0021-9258(19)50210-1 ↗
96. 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K ↗
97. 10.1002/ppap.20100000910.1002/ppap.201000009 ↗
98. 10.1016/j.surfcoat.2013.06.00110.1016/j.surfcoat.2013.06.001 ↗
99. 10.1089/ten.tec.2013.070110.1089/ten.tec.2013.0701 ↗
100. 10.1016/j.actbio.2016.09.03010.1016/j.actbio.2016.09.030 ↗